An interventional study of Electronic Decision Aid Tool in Acute Myeloid Leukemia, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-15.
Sponsored by Duke University · Not applicable, Interventional, and Supportive care
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options.
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options. The objective of our program of research is to ultimately improve understanding about what patients with Acute Myeloid Leukemia (AML) know and understand about their disease, as well as what kind of information AML patients want or need to further inform them about the treatment decisions they face.
The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path. Recruited subjects will complete a series of surveys, both before viewing of the videos and after
Receiving care at Duke, and fits into one of the following scenarios:
Exclusion Criteria:
For this study, we will be testing a novel electronic decision aid to improve Acute Myeloid Leukemia patients' understanding of their illness, prognosis, and treatment options.
Other: Electronic Decision Aid Tool
The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path.
Number of enrolled subjects who have completed the study
Feasibility will be determined by enrolled subjects who complete the study (including watching all videos, and completing the surveys).
Time frame: 1 day
Change in knowledge about AML after video viewing
Efficacy will be measured by change in knowledge about AML, (including knowledge about the disease itself, and comprehending AML treatment choices and their risks, as measured through changes in AML Knowledge Questionnaire scores)
Time frame: Day 1. Pre-video screening and post-video
Changes in Attitudes Towards Chemotherapy Scale scores
Changes in Attitudes Towards Chemotherapy Scale scores,
Time frame: Day 1. Pre-video screening and post-video
Changes in Decisional Conflict Scale scores
Changes in Decisional Conflict Scale scores
Time frame: Day 1. Pre-video screening and post-video
Changes in Anxiety Scores
Changes in Anxiety Scores
Time frame: Day 1. Pre-video screening and post-video
Plan to share: No
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke University